Position in GILD
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$337,706
-$42,495 QoQ
Shares Held
2,673
-2.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,588
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LEAVELL INVESTMENT MANAGEMENT, INC. holds $56,783,148 across 9 Drug Manufacturers - General names. GILD ranks #9 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
74,935 | $18,856,643 | |
| 2 | LLY |
ELI LILLY & Co
|
9,341 | $11,203,876 | |
| 3 | JNJ |
Johnson & Johnson
|
40,591 | $10,308,896 | |
| 4 | AMGN |
Amgen Inc
|
17,935 | $6,494,622 | |
| 5 | MRK |
Merck & Co., Inc.
|
41,794 | $5,370,529 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
36,579 | $2,107,681 | |
| 7 | AZN |
Astrazeneca PLC
|
6,562 | $1,244,286 | |
| 8 | PFE |
Pfizer Inc
|
35,669 | $858,909 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $337,706 | 2,673 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $380,201 | 2,728 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $299,117 | 2,437 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $344,433 | 3,103 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $359,551 | 3,243 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $463,438 | 4,136 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $449,841 | 4,870 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $375,184 | 4,475 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $387,029 | 5,641 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $634,271 | 8,659 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $320,070 | 3,951 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $293,240 | 3,913 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $301,574 | 3,913 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $324,661 | 3,913 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $369,412 | 4,303 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $312,028 | 5,058 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $300,891 | 4,868 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $296,655 | 4,990 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $326,018 | 4,490 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $304,406 | 4,358 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $254,162 | 3,691 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $238,549 | 3,691 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $206,881 | 3,551 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $224,387 | 3,551 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $273,213 | 3,551 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $219,420 | 2,935 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||